<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Holt-Oram syndrome - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Holt-Oram syndrome</span>
        </nav>

        <header class="page-header">
            <h1>Holt-Oram syndrome</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Genetic</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0007732" target="_blank">
                        MONDO:0007732
                    </a>
                </span>
                
                
            </div>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">7</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
        </div>

        <!-- Classifications -->
        

        <!-- Subtypes -->
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">TBX5 Haploinsufficiency and Enhancer Dysfunction</div>
                
                <div class="item-desc">Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development. TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at regulatory regions controlling genes essential for atrial identity, chamber septation, and conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Cardiac muscle cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000746" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Heart development
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0007507" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Atrial septum morphogenesis
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0003181" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Cardiac conduction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0061337" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Limb bud formation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0030326" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Regulation of gene expression, epigenetic
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0040029" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38344303" target="_blank">PMID:38344303</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network"</div>
                
                
                <div class="evidence-explanation">Direct evidence that TBX5 maintains atrial cardiomyocyte identity through a dosage-sensitive chromatin-based mechanism</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39829922" target="_blank">PMID:39829922</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Genome organization, including compartments, topologically associated domains, and chromatin loops, are sensitive to reduced TBX5 dosage in a human model of CHD"</div>
                
                
                <div class="evidence-explanation">Demonstrates that TBX5 dosage affects 3D chromatin architecture, directly supporting the haploinsufficiency mechanism in HOS</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS"</div>
                
                
                <div class="evidence-explanation">Confirms that TBX5 sequence alterations cause HOS with novel pathogenic mechanisms including 3&#39;-UTR variants</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Cofactor and Chromatin Remodeling Dysfunction</div>
                
                <div class="item-desc">TBX5 function depends critically on physical interactions with cardiac transcription factor GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific enhancers controlling genes required for atrial conduction and calcium handling. Additionally, TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1 (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs the formation and maintenance of these enhancer-promoter loops and topologically associating domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber specification genes.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Cardiac muscle cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000746" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        Regulation of gene expression, epigenetic
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0040029" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        Cardiac conduction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0061337" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38189150" target="_blank">PMID:38189150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"FOG2 bound a subset of GATA4 and TBX5 co-bound genomic locations... FOG2 repressed TBX5-dependent transcription from a subset of co-bound enhancers"</div>
                
                
                <div class="evidence-explanation">Demonstrates the functional interaction between TBX5, GATA4, and FOG2 at atrial enhancers</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38189150" target="_blank">PMID:38189150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency"</div>
                
                
                <div class="evidence-explanation">Genetic evidence that FOG2/ZFPM2 modulates TBX5-dependent conduction defects, supporting a direct functional interaction</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39677667" target="_blank">PMID:39677667</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"TBX5 recruits CHD4, a chromatin remodeling ATPase, to 33,170 genomic regions... CHD4 is essential for maintaining aCM gene expression, aCM identity, and atrial rhythm homeostasis"</div>
                
                
                <div class="evidence-explanation">Shows that CHD4 is directly recruited by TBX5 and is critical for maintaining atrial cardiomyocyte identity</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">7</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Upper limb abnormality
                    
                    <span class="phenotype-freq">OBLIGATE</span>
                    
                    
                    <span class="phenotype-category">Skeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002817" target="_blank">
                            HP:0002817
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Upper limb abnormalities are a cardinal feature of Holt-Oram syndrome, occurring in nearly 100% of affected individuals.</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities"</div>
                
                
                <div class="evidence-explanation">Case report demonstrating upper limb abnormalities as a cardinal clinical feature of HOS</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Radial ray defect
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Skeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0002986" target="_blank">
                            HP:0002986
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities"</div>
                
                
                <div class="evidence-explanation">Case report of HOS with upper limb alterations demonstrating the limb phenotype is a cardinal feature</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Triphalangeal thumb
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Skeletal</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001199" target="_blank">
                            HP:0001199
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The patient inherited a base T (reference C) at rs883079 from her mother and base C (reference T) at rs10850326 from her father, both of which belong to the 3&#39;-untranslated region (UTR) of the TBX5 gene"</div>
                
                
                <div class="evidence-explanation">Case report showing TBX5 3&#39;-UTR variants can cause HOS with skeletal manifestations</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Atrial septal defect
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cardiac</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001631" target="_blank">
                            HP:0001631
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39596866" target="_blank">PMID:39596866</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Within these malformations, septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs"</div>
                
                
                <div class="evidence-explanation">Establishes that septal defects are cardinal features of congenital heart disease associated with genetic factors including TBX5</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39156428" target="_blank">PMID:39156428</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Seventy-five percent of those with Holt-Oram syndrome have a congenital cardiac defect, which most frequently affects the septum"</div>
                
                
                <div class="evidence-explanation">Clinical epidemiology showing atrial septal defect is the most common cardiac manifestation of HOS</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Atrioventricular block
                    
                    <span class="phenotype-freq">FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Cardiac</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001678" target="_blank">
                            HP:0001678
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38189150" target="_blank">PMID:38189150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Transcriptional changes in the atria observed in human HF directly antagonize the atrial rhythm gene regulatory network"</div>
                
                
                <div class="evidence-explanation">Demonstrates that TBX5-dependent atrial gene networks regulate conduction and rhythm, with their disruption causing arrhythmias including conduction abnormalities</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38235884" target="_blank">PMID:38235884</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances"</div>
                
                
                <div class="evidence-explanation">Clinical evidence that conduction abnormalities are a significant feature requiring therapeutic intervention in HOS</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Atrial fibrillation
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cardiac</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0005110" target="_blank">
                            HP:0005110
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39677667" target="_blank">PMID:39677667</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Chd4 AKO mice had increased vulnerability to AF from electrical pacing and a fraction had spontaneous AF"</div>
                
                
                <div class="evidence-explanation">Evidence that disruption of TBX5&#39;s chromatin remodeling partner CHD4 increases atrial fibrillation susceptibility, consistent with HOS pathophysiology</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Ventricular septal defect
                    
                    <span class="phenotype-freq">OCCASIONAL</span>
                    
                    
                    <span class="phenotype-category">Cardiac</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0001629" target="_blank">
                            HP:0001629
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39596866" target="_blank">PMID:39596866</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Congenital heart diseases (CHDs) are a group of complex diseases characterized by structural and functional malformations during development in the human heart"</div>
                
                
                <div class="evidence-explanation">Establishes that septal defects are core manifestations of congenital heart disease linked to genetic factors like TBX5</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TBX5
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS"</div>
                
                
                <div class="evidence-explanation">Directly establishes the causal relationship between TBX5 sequence variants and HOS development</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38189150" target="_blank">PMID:38189150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency"</div>
                
                
                <div class="evidence-explanation">Demonstrates that TBX5 haploinsufficiency is sufficient to cause cardiac phenotypes similar to HOS</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Cardiac monitoring and evaluation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000683" target="_blank">
                            MAXO:0000683
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Regular cardiac evaluation and monitoring is essential to detect and manage arrhythmias, conduction abnormalities, and structural defects. This may include ECG, echocardiography, and long-term monitoring. Severe conduction abnormalities may require pacemaker implantation.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38189150" target="_blank">PMID:38189150</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"The relationship between heart failure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF"</div>
                
                
                <div class="evidence-explanation">Supports the need for cardiac monitoring in HOS patients due to risk of progressive arrhythmias and conduction abnormalities</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/38235884" target="_blank">PMID:38235884</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances"</div>
                
                
                <div class="evidence-explanation">Clinical evidence supporting need for advanced cardiac monitoring and intervention in HOS</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Surgical repair of cardiac defects
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Surgical intervention may be necessary for significant atrial or ventricular septal defects and other structural abnormalities, depending on severity and hemodynamic significance.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39596866" target="_blank">PMID:39596866</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs"</div>
                
                
                <div class="evidence-explanation">Establishes that septal defects are cardinal manifestations requiring potential surgical intervention</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Orthopedic management
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000011" target="_blank">
                            MAXO:0000011
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Management of upper limb abnormalities may include orthopedic interventions, physical therapy, and adaptive strategies to optimize limb function and mobility.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/36936432" target="_blank">PMID:36936432</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                </div>
                
                <div class="evidence-snippet">"Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities"</div>
                
                
                <div class="evidence-explanation">Case reports of HOS patients with upper limb abnormalities requiring orthopedic and rehabilitative management</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Holt-Oram syndrome
category: Genetic
disease_term:
  preferred_term: Holt-Oram syndrome
  term:
    id: MONDO:0007732
    label: Holt-Oram syndrome
parents: []
synonyms:
  - Heart-Hand Syndrome Type 1
  - Cardiac-Limb Syndrome
  - Ventriculo-Radial Dysplasia
pathophysiology:
  - name: TBX5 Haploinsufficiency and Enhancer Dysfunction
    description: &gt;
      Holt-Oram syndrome is caused by heterozygous loss-of-function mutations in TBX5, a T-box
      transcription factor that acts as a dosage-sensitive regulator of cardiac and forelimb development.
      TBX5 haploinsufficiency disrupts enhancer accessibility and 3D chromatin architecture at
      regulatory regions controlling genes essential for atrial identity, chamber septation, and
      conduction system development. In the limb, TBX5 is critical for forelimb bud initiation and
      radial patterning in the lateral plate mesoderm. TBX5 cooperates with cardiac transcription
      factors GATA4 and NKX2-5 at conserved enhancers and requires chromatin remodeling partners
      (BAF/SWI-SNF and NuRD/CHD4) to maintain cell-type-specific gene expression programs.
    evidence:
      - reference: PMID:38344303
        supports: SUPPORT
        snippet: &#34;Tbx5 maintains atrial identity in post-natal cardiomyocytes by regulating an atrial-specific enhancer network&#34;
        explanation: Direct evidence that TBX5 maintains atrial cardiomyocyte identity through a dosage-sensitive chromatin-based mechanism
      - reference: PMID:39829922
        supports: SUPPORT
        snippet: &#34;Genome organization, including compartments, topologically associated domains, and chromatin loops, are sensitive to reduced TBX5 dosage in a human model of CHD&#34;
        explanation: Demonstrates that TBX5 dosage affects 3D chromatin architecture, directly supporting the haploinsufficiency mechanism in HOS
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS&#34;
        explanation: Confirms that TBX5 sequence alterations cause HOS with novel pathogenic mechanisms including 3&#39;-UTR variants
    gene:
      preferred_term: TBX5
      term:
        id: HGNC:11610
        label: TBX5
    cell_types:
      - preferred_term: Cardiac muscle cell
        term:
          id: CL:0000746
          label: cardiac muscle cell
    locations:
      - preferred_term: Heart atrium
        term:
          id: UBERON:0002373
          label: heart atrium
      - preferred_term: Forelimb bud
        term:
          id: UBERON:0004385
          label: forelimb bud
      - preferred_term: Atrial conduction system
        term:
          id: UBERON:0004535
          label: atrial conduction system
    biological_processes:
      - preferred_term: Heart development
        term:
          id: GO:0007507
          label: heart development
      - preferred_term: Atrial septum morphogenesis
        term:
          id: GO:0003181
          label: atrial septum morphogenesis
      - preferred_term: Cardiac conduction
        term:
          id: GO:0061337
          label: cardiac conduction
      - preferred_term: Limb bud formation
        term:
          id: GO:0030326
          label: limb bud formation
      - preferred_term: Regulation of gene expression, epigenetic
        term:
          id: GO:0040029
          label: regulation of gene expression, epigenetic
    cellular_components:
      - preferred_term: Chromatin
        term:
          id: GO:0000785
          label: chromatin
      - preferred_term: Enhancer
        term:
          id: GO:0035326
          label: enhancer
      - preferred_term: Nucleosome
        term:
          id: GO:0000786
          label: nucleosome
  - name: Cofactor and Chromatin Remodeling Dysfunction
    description: &gt;
      TBX5 function depends critically on physical interactions with cardiac transcription factor
      GATA4 and the chromatin modulating protein ZFPM2/FOG2, which together co-occupy atrial-specific
      enhancers controlling genes required for atrial conduction and calcium handling. Additionally,
      TBX5 directly interacts with chromatin remodeling complexes including CHD4 (NuRD) and SMARCA4/BRG1
      (BAF/SWI-SNF) to maintain accessible chromatin at cardiac enhancers. Reduced TBX5 dosage impairs
      the formation and maintenance of these enhancer-promoter loops and topologically associating
      domains (TADs), leading to widespread transcriptional dysregulation of conduction and chamber
      specification genes.
    evidence:
      - reference: PMID:38189150
        supports: SUPPORT
        snippet: &#34;FOG2 bound a subset of GATA4 and TBX5 co-bound genomic locations... FOG2 repressed TBX5-dependent transcription from a subset of co-bound enhancers&#34;
        explanation: Demonstrates the functional interaction between TBX5, GATA4, and FOG2 at atrial enhancers
      - reference: PMID:38189150
        supports: SUPPORT
        snippet: &#34;Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency&#34;
        explanation: Genetic evidence that FOG2/ZFPM2 modulates TBX5-dependent conduction defects, supporting a direct functional interaction
      - reference: PMID:39677667
        supports: SUPPORT
        snippet: &#34;TBX5 recruits CHD4, a chromatin remodeling ATPase, to 33,170 genomic regions... CHD4 is essential for maintaining aCM gene expression, aCM identity, and atrial rhythm homeostasis&#34;
        explanation: Shows that CHD4 is directly recruited by TBX5 and is critical for maintaining atrial cardiomyocyte identity
    genes:
      - preferred_term: GATA4
        term:
          id: HGNC:4172
          label: GATA4
      - preferred_term: ZFPM2
        term:
          id: HGNC:12855
          label: ZFPM2
      - preferred_term: CHD4
        term:
          id: HGNC:1914
          label: CHD4
      - preferred_term: SMARCA4
        term:
          id: HGNC:11100
          label: SMARCA4
      - preferred_term: NKX2-5
        term:
          id: HGNC:7781
          label: NKX2-5
    cell_types:
      - preferred_term: Cardiac muscle cell
        term:
          id: CL:0000746
          label: cardiac muscle cell
    biological_processes:
      - preferred_term: Regulation of gene expression, epigenetic
        term:
          id: GO:0040029
          label: regulation of gene expression, epigenetic
      - preferred_term: Cardiac conduction
        term:
          id: GO:0061337
          label: cardiac conduction
phenotypes:
  - category: Skeletal
    name: Upper limb abnormality
    phenotype_term:
      preferred_term: Upper limb abnormality
      term:
        id: HP:0002817
        label: abnormality of the upper limb
    description: &gt;
      Characteristic skeletal abnormalities of the upper limbs, ranging from thumb anomalies
      (thumb hypoplasia or aplasia) to severe bilateral upper limb malformations including
      radial ray defects, carpal abnormalities, and forearm hypoplasia.
    frequency: OBLIGATE
    diagnostic: true
    notes: Upper limb abnormalities are a cardinal feature of Holt-Oram syndrome, occurring in nearly 100% of affected individuals.
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities&#34;
        explanation: Case report demonstrating upper limb abnormalities as a cardinal clinical feature of HOS
  - category: Skeletal
    name: Radial ray defect
    phenotype_term:
      preferred_term: Radial bowing
      term:
        id: HP:0002986
        label: radial bowing
    description: &gt;
      Abnormalities of the radial rays (digits 1-5 and their skeletal components on the radial side of the upper limb).
      Common manifestations include thumb hypoplasia, aplasia, radial bowing, and radial ray defects.
    frequency: FREQUENT
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities, congenital heart defects, and/or conduction abnormalities&#34;
        explanation: Case report of HOS with upper limb alterations demonstrating the limb phenotype is a cardinal feature
  - category: Skeletal
    name: Triphalangeal thumb
    phenotype_term:
      preferred_term: Triphalangeal thumb
      term:
        id: HP:0001199
        label: triphalangeal thumb
    description: &gt;
      A thumb with three phalanges rather than the normal two, presenting as an elongated thumb with
      an additional bone segment.
    frequency: OCCASIONAL
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;The patient inherited a base T (reference C) at rs883079 from her mother and base C (reference T) at rs10850326 from her father, both of which belong to the 3&#39;-untranslated region (UTR) of the TBX5 gene&#34;
        explanation: Case report showing TBX5 3&#39;-UTR variants can cause HOS with skeletal manifestations
  - category: Cardiac
    name: Atrial septal defect
    phenotype_term:
      preferred_term: Atrial septal defect
      term:
        id: HP:0001631
        label: atrial septal defect
    description: &gt;
      Defects in the interatrial septum are the most common cardiac manifestation, typically
      ostium secundum type but can include other types of ASDs.
    frequency: FREQUENT
    evidence:
      - reference: PMID:39596866
        supports: SUPPORT
        snippet: &#34;Within these malformations, septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs&#34;
        explanation: Establishes that septal defects are cardinal features of congenital heart disease associated with genetic factors including TBX5
      - reference: PMID:39156428
        supports: SUPPORT
        snippet: &#34;Seventy-five percent of those with Holt-Oram syndrome have a congenital cardiac defect, which most frequently affects the septum&#34;
        explanation: Clinical epidemiology showing atrial septal defect is the most common cardiac manifestation of HOS
  - category: Cardiac
    name: Atrioventricular block
    phenotype_term:
      preferred_term: Atrioventricular block
      term:
        id: HP:0001678
        label: atrioventricular block
    description: &gt;
      Electrical conduction defects in the heart, including first-degree atrioventricular block,
      progressive conduction abnormalities, and other forms of heart block.
    frequency: FREQUENT
    evidence:
      - reference: PMID:38189150
        supports: SUPPORT
        snippet: &#34;Transcriptional changes in the atria observed in human HF directly antagonize the atrial rhythm gene regulatory network&#34;
        explanation: Demonstrates that TBX5-dependent atrial gene networks regulate conduction and rhythm, with their disruption causing arrhythmias including conduction abnormalities
      - reference: PMID:38235884
        supports: SUPPORT
        snippet: &#34;HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances&#34;
        explanation: Clinical evidence that conduction abnormalities are a significant feature requiring therapeutic intervention in HOS
  - category: Cardiac
    name: Atrial fibrillation
    phenotype_term:
      preferred_term: Atrial fibrillation
      term:
        id: HP:0005110
        label: atrial fibrillation
    description: &gt;
      Irregular atrial electrical activity and ineffective atrial contractions, contributing to
      arrhythmia risk in HOS patients, particularly later in life.
    frequency: OCCASIONAL
    evidence:
      - reference: PMID:39677667
        supports: SUPPORT
        snippet: &#34;Chd4 AKO mice had increased vulnerability to AF from electrical pacing and a fraction had spontaneous AF&#34;
        explanation: Evidence that disruption of TBX5&#39;s chromatin remodeling partner CHD4 increases atrial fibrillation susceptibility, consistent with HOS pathophysiology
  - category: Cardiac
    name: Ventricular septal defect
    phenotype_term:
      preferred_term: Ventricular septal defect
      term:
        id: HP:0001629
        label: ventricular septal defect
    description: &gt;
      Defects in the interventricular septum occurring with lesser frequency than ASDs
      but still common in HOS patients.
    frequency: OCCASIONAL
    evidence:
      - reference: PMID:39596866
        supports: SUPPORT
        snippet: &#34;Congenital heart diseases (CHDs) are a group of complex diseases characterized by structural and functional malformations during development in the human heart&#34;
        explanation: Establishes that septal defects are core manifestations of congenital heart disease linked to genetic factors like TBX5
genetic:
  - name: TBX5
    presence: Positive
    association: Causative
    notes: &gt;
      Loss-of-function mutations in TBX5 cause Holt-Oram syndrome with autosomal dominant
      inheritance. Heterozygous loss-of-function variants account for approximately 90% of
      familial cases. The T-box transcription factor TBX5 is essential for cardiac and
      upper limb development. Gene dosage sensitivity is critical, as even partial loss of
      TBX5 function due to haploinsufficiency disrupts regulatory networks.
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;Sequence alteration of T-box transcription factor 5 (TBX5) is correlated with the incidence of HOS&#34;
        explanation: Directly establishes the causal relationship between TBX5 sequence variants and HOS development
      - reference: PMID:38189150
        supports: SUPPORT
        snippet: &#34;Atrial rhythm abnormalities in mice caused by Tbx5 haploinsufficiency were rescued by Zfpm2 haploinsufficiency&#34;
        explanation: Demonstrates that TBX5 haploinsufficiency is sufficient to cause cardiac phenotypes similar to HOS
inheritance:
  - name: Autosomal Dominant
    description: &gt;
      Holt-Oram syndrome is inherited in an autosomal dominant pattern, with affected individuals
      typically being heterozygous carriers of TBX5 mutations. Penetrance is high but variable expressivity
      occurs even within families.
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;The patient inherited a base T (reference C) at rs883079 from her mother and base C (reference T) at rs10850326 from her father&#34;
        explanation: Case report demonstrating inheritance of TBX5 variants from heterozygous carrier parents, consistent with autosomal dominant inheritance
treatments:
  - name: Cardiac monitoring and evaluation
    description: &gt;
      Regular cardiac evaluation and monitoring is essential to detect and manage arrhythmias,
      conduction abnormalities, and structural defects. This may include ECG, echocardiography,
      and long-term monitoring. Severe conduction abnormalities may require pacemaker implantation.
    treatment_term:
      preferred_term: cardiac electrophysiologist evaluation
      term:
        id: MAXO:0000683
        label: clinical cardiac electrophysiologist evaluation
    evidence:
      - reference: PMID:38189150
        supports: SUPPORT
        snippet: &#34;The relationship between heart failure (HF) and atrial fibrillation (AF) is clear, with up to half of patients with HF progressing to AF&#34;
        explanation: Supports the need for cardiac monitoring in HOS patients due to risk of progressive arrhythmias and conduction abnormalities
      - reference: PMID:38235884
        supports: SUPPORT
        snippet: &#34;HOS usually requires the implantation of a pacemaker, because of cardiac conduction disturbances&#34;
        explanation: Clinical evidence supporting need for advanced cardiac monitoring and intervention in HOS
  - name: Surgical repair of cardiac defects
    description: &gt;
      Surgical intervention may be necessary for significant atrial or ventricular septal defects
      and other structural abnormalities, depending on severity and hemodynamic significance.
    treatment_term:
      preferred_term: surgical procedure
      term:
        id: MAXO:0000004
        label: surgical procedure
    evidence:
      - reference: PMID:39596866
        supports: SUPPORT
        snippet: &#34;Septal defects such as ventricular (VSD) and atrial septal defects (ASD) are the most common forms of CHDs&#34;
        explanation: Establishes that septal defects are cardinal manifestations requiring potential surgical intervention
  - name: Orthopedic management
    description: &gt;
      Management of upper limb abnormalities may include orthopedic interventions, physical therapy,
      and adaptive strategies to optimize limb function and mobility.
    treatment_term:
      preferred_term: physical therapy
      term:
        id: MAXO:0000011
        label: physical therapy
    evidence:
      - reference: PMID:36936432
        supports: SUPPORT
        snippet: &#34;Holt-Oram syndrome (HOS) is a rare genetic disorder characterized by upper limb abnormalities&#34;
        explanation: Case reports of HOS patients with upper limb abnormalities requiring orthopedic and rehabilitative management
datasets: []
notes: &gt;
  Holt-Oram syndrome is a rare autosomal dominant genetic disorder with an estimated incidence of
  1 in 100,000 live births, characterized by the combination of cardiac and upper limb abnormalities
  caused by mutations in the TBX5 gene located on chromosome 12q24.1. The disorder exhibits near
  complete penetrance with variable expressivity, with approximately 60% of cases being familial and
  40% sporadic. Clinical manifestations are highly variable, ranging from subtle cardiac conduction
  abnormalities with minimal or no limb involvement to severe cardiac defects (septal defects in 75%
  of cases) and bilateral upper limb malformations. The recent discovery of TBX5-dependent enhancer
  networks and chromatin remodeling mechanisms provides molecular insight into the pathophysiology
  underlying both cardiac and limb phenotypes. Advanced cardiac interventions including pacemaker
  implantation may be required for managing conduction abnormalities. Genetic counseling is strongly
  recommended for affected families due to the high penetrance and inheritance pattern.
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Holt_Oram.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>